Davidson Michael H. sold NAMS

February 26, 2026 · Form 4 insider transaction

Davidson Michael H. sold 17,924 shares of NewAmsterdam Pharma Company N.V. at $34.44 per share, a transaction worth $617.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
17,924
Price
$34.44
Total value
$617.3K
RoleOfficer, Director
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2026
Filing dateFebruary 26, 2026
Shares owned after174,144
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.35 to $34.82 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.; The amount reported in Column 5 reflects the transfer of 285,715 ordinary shares from the Reporting Person to the Michael H. Davidson 2026 Grantor Retained Annuity Trust (the "GRAT") on February 26, 2026, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. The Reporting Person is the sole annuitant and trustee of the GRAT.

View the original Form 4 on SEC EDGAR